Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Flexi-CAL
- Development stage
- Unknown
- Lead developer
- AnaStellar Brands
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Flexi-CAL is a comprehensive 5-in-1 nutritional supplement developed by AnaStellar Brands, a South African pharmaceutical company. It is designed to support the entire musculoskeletal system, including bones, joints, and muscles. The product is formulated as a triple-action pack containing three distinct oral components: a yellow joint complex tablet (containing MSM, chondroitin, B-complex vitamins, amino acids, and antioxidants), a white calcium and collagen tablet (containing calcium, type I hydrolyzed collagen, vitamin D3, magnesium, and vitamin K2), and a clear omega-3 softgel capsule (containing EPA and DHA). Flexi-CAL targets multiple biological pathways, including the vitamin D receptor, vitamin K-dependent gamma-carboxylase, calcium-sensing receptor, and peroxisome proliferator-activated receptor (PPAR). It is primarily indicated for musculoskeletal support and the management of conditions such as osteoarthritis and osteoporosis by providing anti-inflammatory properties, joint lubrication, and bone strength support.
- Brand names
- Flexi-CAL
02
Targets
VDR (Vitamin D receptor)CaSR (Extracellular calcium-sensing receptor)PPAR (PPAR family)GGCX (Vitamin K-dependent gamma-glutamyl carboxylase)
Beyond the preview
Go deeper on Flexi-CAL.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Flexi-CAL.